V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003090 | 210006504 | 1.68 | 58 | Palliative (P) | 2018-02-22 | 2018-03-09 | FEC + DOCETAXEL | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100973773 |
| 210003100 | 210006511 | null | null | null | 2016-09-14 | 2016-09-21 | FEC + DOCETAXEL | null | null | FEC + DOCETAXEL | 100674209 |
| 210003101 | 210006512 | 1.63 | 64 | Palliative (P) | 2019-02-24 | 2019-04-30 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100956743 |
| 210003103 | 210006513 | null | 68.15 | null | 2016-08-27 | 2016-09-12 | EC | null | null | EC | 101489039 |
| 210003105 | 210006514 | 1.57 | 62.6 | Palliative (P) | null | 2017-07-24 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100718817 |
| 210003107 | 210006515 | 1.68 | null | Curative (C) | 2016-05-11 | 2016-06-03 | FEC 100 | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100351406 |
| 210003108 | 210006516 | 1.57 | 79.45 | Adjuvant (A) | 2016-08-03 | 2016-08-18 | null | 02 | null | CARBOPLATIN | 101031930 |
| 210003111 | 210006517 | 1.53 | 55.05 | Palliative (P) | 2018-06-11 | 2018-06-12 | FEC 100 | N | N | FEC | 100304112 |
| 210003115 | 210006521 | null | 59 | null | 2020-07-15 | 2020-10-02 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | null | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100764951 |
| 210003117 | 210006523 | 1.65 | 66 | Palliative (P) | 2018-10-28 | 2019-01-27 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101533048 |
| 210003119 | 210006525 | 1.61 | 70.35 | Adjuvant (A) | 2017-08-30 | 2018-06-10 | null | null | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 101666789 |
| 210003121 | 210006527 | 1.6 | 84 | Palliative (P) | null | 2019-08-24 | FEC 100 | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100552009 |
| 210003123 | 210006529 | null | null | null | null | 2019-07-27 | Capecitabine | null | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100635694 |
| 210003124 | 210006530 | 1.53 | 71.2 | Neo-adjuvant (N) | 2017-06-07 | 2017-06-10 | Epirubicin | 02 | N | CARBOPLATIN + GEMCITABINE | 101697396 |
| 210003126 | 210006531 | 1.66 | 83.3 | Palliative (P) | 2017-12-18 | 2017-12-31 | FEC 100 | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101022568 |
| 210003127 | 210006532 | 1.58 | 114.4 | Neo-adjuvant (N) | null | 2020-03-01 | Abemaciclib | 02 | N | CARBOPLATIN + PACLITAXEL | 100351543 |
| 210003129 | 210006533 | 1.7 | 71 | Neo-adjuvant (N) | null | 2018-07-14 | Paclitaxel+Trastuzumab wkly Maint | null | N | PACLITAXEL + TRASTUZUMAB | 101151851 |
| 210003135 | 210006537 | null | null | null | null | 2017-01-27 | null | null | null | CARBOPLATIN + GEMCITABINE | 101066007 |
| 210003136 | 210006538 | null | null | null | 2016-06-23 | 2016-07-09 | EC | null | null | EC | 101852150 |
| 210003137 | 210006539 | 1.49 | 65.2 | Palliative (P) | 2016-04-07 | 2016-05-27 | FEC + DOCETAXEL | N | N | FEC + DOCETAXEL | 101688526 |
| 210003138 | 210006540 | null | null | null | 2017-01-04 | 2017-01-25 | FEC 100 | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100463305 |
| 210003139 | 210006541 | null | 66.2 | null | 2017-09-10 | 2017-09-23 | OCTREOTIDE | 02 | null | CAPECITABINE | 100747922 |
| 210003141 | 210006542 | 1.73 | 53.55 | null | 2016-11-23 | 2016-12-07 | TCH (21 day Trastuzumab) Maint | null | null | CYTARABINE | 101176554 |
| 210003143 | 210006544 | 1.7 | 92.8 | null | 2018-07-14 | 2018-07-19 | EC | null | null | EC | 100988985 |
| 210003144 | 210006545 | null | null | null | 2020-01-17 | 2020-01-18 | null | 02 | null | PALBOCICLIB | 100904106 |
| 210003146 | 210006547 | 1.6 | 96 | Palliative (P) | 2017-01-01 | 2017-01-15 | EC | 02 | N | EC | 100641036 |
| 210003147 | 210006548 | 1.5 | 47 | Palliative (P) | 2018-06-13 | 2018-06-23 | FEC + DOCETAXEL | 02 | N | FEC + DOCETAXEL | 101213383 |
| 210003149 | 210006550 | null | 101 | null | 2016-06-18 | 2016-06-21 | Trial Unspecified | null | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 101333903 |
| 210003150 | 210006551 | 1.72 | 63.6 | Palliative (P) | 2018-09-02 | 2018-09-24 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101854643 |
| 210003151 | 210006552 | 1.54 | 96.6 | Palliative (P) | 2017-12-28 | 2018-01-04 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100910185 |
| 210003152 | 210006553 | null | 58.05 | null | null | 2019-08-30 | Letrozole + Palbociclib | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101399222 |
| 210003154 | 210006555 | 1.57 | 134.5 | null | null | 2019-03-02 | FEC 100 | null | null | FEC | 101747755 |
| 210003156 | 210006556 | 1.69 | 77.8 | null | 2019-02-04 | 2019-02-04 | FEC 100 | N | null | FEC | 100730190 |
| 210003157 | 210006557 | 1.67 | 65.6 | null | 2016-03-30 | 2016-04-23 | Paclitaxel+Trastuzumab wkly Maint | null | null | PACLITAXEL + TRASTUZUMAB | 100040142 |
| 210003158 | 210006558 | 1.63 | 86.3 | null | null | 2018-04-21 | FEC + DOCETAXEL | null | null | FEC + DOCETAXEL | 100735496 |
| 210003162 | 210006561 | 1.67 | 53.9 | Palliative (P) | null | 2016-04-29 | Capecitabine | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100331511 |
| 210003164 | 210006563 | 1.57 | 49.7 | Adjuvant (A) | 2017-03-10 | 2017-04-01 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 100322804 |
| 210003165 | 210006564 | 1.66 | 78.7 | Palliative (P) | 2018-09-18 | 2018-12-13 | null | 02 | N | ABEMACICLIB + FULVESTRANT | 101835916 |
| 210003169 | 210006568 | 1.62 | 73.7 | Palliative (P) | 2016-09-07 | 2016-09-19 | FEC 100 | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100296691 |
| 210003170 | 210006569 | 1.53 | 75.95 | null | 2017-03-22 | 2017-04-14 | null | 02 | null | POMALIDOMIDE | 101062258 |
| 210003175 | 210006573 | 1.61 | 115.6 | Adjuvant (A) | null | 2018-07-01 | CARBOPLATIN + PACLITAXEL | null | N | LETROZOLE + PALBOCICLIB | 101065228 |
| 210003177 | 210006574 | null | 80.5 | null | 2018-06-10 | 2018-06-17 | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL + Trastuzumab | N | null | CARBOPLATIN + PACLITAXEL | 100715959 |
| 210003178 | 210006575 | 1.66 | null | Adjuvant (A) | 2021-04-19 | 2021-04-19 | null | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101816553 |
| 210003180 | 210006577 | 1.66 | 74.8 | Adjuvant (A) | null | 2017-07-20 | FEC 100 | 02 | N | EC | 100849065 |
| 210003181 | 210006578 | null | null | null | 2020-06-19 | 2020-09-01 | null | N | null | EC | 100302192 |
| 210003182 | 210006579 | 1.65 | 59.2 | Adjuvant (A) | 2018-11-09 | 2018-11-18 | null | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL + PERTUZUMAB + TRASTUZUMAB | 100777017 |
| 210003186 | 210006581 | 1.69 | 60.2 | Neo-adjuvant (N) | null | 2018-09-21 | Fulvestrant + Palbociclib | null | N | CARBOPLATIN + GEMCITABINE | 101501469 |
| 210003188 | 210006582 | 1.7 | 84.1 | Palliative (P) | 2017-03-30 | 2017-03-31 | FEC + DOCETAXEL | null | N | FEC + DOCETAXEL | 100232619 |
| 210003193 | 210006585 | 0 | 68.1 | null | 2017-09-12 | 2017-10-24 | DOCETAXEL + TRASTUZUMAB | null | null | PACLITAXEL + TRASTUZUMAB | 101684009 |
| 210003194 | 210006586 | 1.66 | 0 | Palliative (P) | null | 2017-08-16 | null | null | Y | LETROZOLE + PALBOCICLIB | 101493971 |